Benralizumab is effective in reducing asthma exacerbations: Results from the ZEPHYR 2 study

被引：0
|
作者：
Maselli, Diego J.
Carstens, Donna
Yang, Danni
Mu, Fan
Young, Joshua
Cook, Erin E.
Betts, Keith A.
Chung, Yen
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2022年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [21] LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial
    FitzGerald, J. Mark
    Bleecker, Eugene
    Nair, Parameswaran
    Korn, Stephanie
    Ohta, Ken
    Lommatzsch, Marek
    Ferguson, Gary
    Busse, William
    Barker, Peter
    Sproule, Stephanie
    Gilmartin, Geoffrey
    Werkstrom, Viktoria
    Aurivillius, Magnus
    Goldman, Mitchell
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [22] Reducing inhaled corticosteroids in patients well controlled on benralizumab: experience from a tertiary severe asthma service
    Willoughby, Shay
    Burton, Rachel
    Fyles, Fred
    Joplin, Hannah
    Abraham, Anita
    Nuttall, Amy
    Burhan, Hassan
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [23] Sustained Effectiveness of Benralizumab in Naive and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study
    Cameli, Paolo
    Aliani, Maria
    Altieri, Elena
    Bracciale, Pietro
    Brussino, Luisa
    Caiaffa, Maria Filomena
    Canonica, Giorgio Walter
    Caruso, Cristiano
    Centanni, Stefano
    D'Amato, Maria
    De Michele, Fausto
    Del Giacco, Stefano
    Di Marco, Fabiano
    Pelaia, Girolamo
    Rogliani, Paola
    Romagnoli, Micaela
    Schino, Pietro
    Schroeder, Jan Walter
    Senna, Gianenrico
    Vultaggio, Alessandra
    Benci, Marco
    Boarino, Silvia
    Menzella, Francesco
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 273 - 290
  • [24] Prediction of asthma exacerbations in children: results of a one-year prospective study
    Robroeks, C. M. H. H. T.
    van Vliet, D.
    Jobsis, Q.
    Braekers, R.
    Rijkers, G. T.
    Wodzig, W. K. W. H.
    Bast, A.
    Zimmermann, L. J. I.
    Dompeling, E.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (05): : 792 - 798
  • [25] Indacaterol/glycopyrronium (IND/GLY) is more effective than salmeterol/fluticasone (SFC) in reducing exacerbations, regardless of outcome measurement utilised: Results from the FLAME study
    Keininger, Dorothy
    Wedzicha, Jadwiga A.
    Vestbo, Jorgen
    Ayers, Tim
    FowlerTaylor, Angel
    Thach, Chau
    Larbig, Michael
    Askin, Elaine
    Fogel, Robert
    Patalano, Francesco
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [26] BENRALIZUMAB IS EFFECTIVE AT REDUCING AIRWAY INFLAMMATION IN SEVERE ASTHMA PATIENTS FOLLOWING NON-RESPONSE TO MEPOLIZUMAB ASSOCIATED WITH PERSISTENT SPUTUM EOSINOPHILIA
    Tavernier, G.
    Aspin, P.
    Holmes, L. J.
    Elsey, L.
    Niven, R.
    Pantin, C. T.
    Allen, D.
    Fowler, S. J.
    THORAX, 2021, 76 : A82 - A83
  • [27] Reducing Exacerbations in the Inner City: Lessons from the Inner-City Asthma Consortium (ICAC)
    Gergen, Peter J.
    Teach, Stephen J.
    Togias, Alkis
    Busse, William W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (01): : 22 - 26
  • [28] TEZEPELUMAB IS EFFECTIVE IN REDUCING EXACERBATIONS AFTER BIOLOGIC SWITCHING: REAL-WORLD EXPERIENCE IN A COHORT OF IN SEVERE ASTHMA PATIENTS
    Bagheri, Amirbehzad
    Senn, Rebecca
    Harwood, Hannah
    Derstine, Brian
    Mohan, Arjun
    Lugogo, Njira L.
    CHEST, 2023, 164 (04) : 63A - 66A
  • [29] BENRALIZUMAB REAL-WORLD EFFECTIVENESS ON EXACERBATIONS AMONG US SPECIALIST-TREATED PATIENTS WITH SEVERE ASTHMA: DATA FROM CHRONICLE
    Panettieri, R.
    Lugogo, N.
    Moore, W.
    Chipps, B.
    Jepson, B.
    Zhou, W.
    Ambrose, C.
    Genofre, E.
    Carstens, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S30 - S31
  • [30] A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan
    Park, Hae-Sim
    Kim, Mi-Kyeong
    Imai, Nobuyuki
    Nakanishi, Tsutomu
    Adachi, Mitsuru
    Ohta, Ken
    Tohda, Yuji
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2016, 169 (03) : 135 - 145
12345